English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?

Outeiro, T. F., Harvey, K., Dominguez-Meijide, A., & Gerhardt, E. (2019). LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions, 47(3), 827-838. doi:10.1042/BST20180466.

Item is

Files

show Files
hide Files
:
bst-2018-0466c.pdf (Publisher version), 2MB
 
File Permalink:
-
Name:
bst-2018-0466c.pdf
Description:
2019-05-13
OA-Status:
Visibility:
Restricted ( Max Planck Society (every institute); )
MIME-Type / Checksum:
application/pdf
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Outeiro, Tiago F.1, Author           
Harvey, Kirsten, Author
Dominguez-Meijide, Antonio, Author
Gerhardt, Ellen, Author
Affiliations:
1Experimental Neurodegeneration, Max Planck Institute of Experimental Medicine, Max Planck Society, ou_3398149              

Content

show
hide
Free keywords: alpha-synuclein, LRRK2, neurodegeneration, Parkinson's disease, tau
 Abstract: The identification of genetic forms of Parkinson's disease (PD) has tremendously expanded our understanding of the players and mechanisms involved. Mutations in the genes encoding for alpha-synuclein (aSyn), LRRK2, and tau have been associated with familial and sporadic forms of the disease. aSyn is the major component of Lewy bodies and Lewy neurites, which are pathognomonic protein inclusions in PD. Hyperphosphorylated tau protein accumulates in neurofibrillary tangles in the brains of Alzheimer's disease patients but is also seen in the brains of PD patients. LRRK2 is a complex multi-domain protein with kinase and GTPase enzymatic activity. Since aSyn and tau are phosphoproteins, we review the possible interplay between the three proteins. Understanding the interplay between LRRK2, aSyn and tau is extremely important, as this may enable the identification of novel targets and pathways for therapeutic intervention.

Details

show
hide
Language(s): eng - English
 Dates: 2019-04-232019-05-132019-06
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1042/BST20180466
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Biochemical Society Transactions
  Other : Biochem Soc Trans
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: London, UK : Portland Press
Pages: - Volume / Issue: 47 (3) Sequence Number: - Start / End Page: 827 - 838 Identifier: ISSN: 0300-5127
CoNE: https://pure.mpg.de/cone/journals/resource/954925507337